Patents by Inventor A. Sinclair

A. Sinclair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230220475
    Abstract: The present invention provides methods, compositions and kits for assembling an enzyme-deoxyribonucleic acid (DNA) complex for use in preparing a double stranded DNA molecule comprising one or more loci of interest for determining the methylation status of the one or more loci of interest therein.
    Type: Application
    Filed: June 11, 2021
    Publication date: July 13, 2023
    Inventors: Patrick Thomas Griffin, David A. Sinclair
  • Patent number: 11698526
    Abstract: A multi channel beamsplitter system operating over a wide spectral band has high optical performance despite the fact that the incoming and/or exiting light is not collimated and its material is dispersive. This is achieved using wavefront compensators that are matched to the curvature of the wavefronts of the incoming and/or exiting light.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: July 11, 2023
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Matthew A. Sinclair, Adam F. Kelsey, David A. Landis, Stephanie L. Golmon, Buddy Clemmer, Juha-Pekka Laine
  • Patent number: 11686572
    Abstract: The present disclosure provides an OCT imaging system to reduce or eliminate frequency-domain aliasing artifacts. The frequency is shifted using a carrier frequency to define a sampling range substantially centered on the carrier frequency. An image of the sample is generated from a displayed imaging range that consists of a subset of the frequencies within the sampling range. Furthermore, the system may be configured to determine the carrier frequency such that a Nyquist frequency corresponding to the shifted frequency is extended beyond either an upper or a lower bound of an OCT quality envelope corresponding to the first portion of light. Additionally, the carrier frequency may be determined such that a lower bound of the OCT quality envelope is greater or less than a zero-frequency DC limit.
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: June 27, 2023
    Assignee: Ninepoint Medical, Inc.
    Inventors: Eman Namati, Muhammad Al-Qaisi, Matthew A. Sinclair, Benedikt Graf, David Vader
  • Publication number: 20230158053
    Abstract: The invention relates to compositions of nicotinamide mononucleotide derivatives and their methods of use. The invention also relates to methods of preparing nicotinamide mononucleotide derivatives. The invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinamide mononucleotide derivative. The invention relates to methods of using nicotinamide mononucleotide derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for treating diseases and improving cell and tissue survival.
    Type: Application
    Filed: July 26, 2022
    Publication date: May 25, 2023
    Inventors: Karl D. Normington, David A. Sinclair, David J. Livingston, James M. McKearin, Bruce Szczepankiewicz, Jonathan N. Kremsky
  • Patent number: 11595630
    Abstract: Techniques to facilitate compression of depth data and real-time reconstruction of high-quality light fields. A parameter space of values for a line, pairs of endpoints on different sides of the line, and a palette index for each pixel of a pixel tile of a depth image is sampled. Values for the line, the pairs of endpoints, and the palette index that minimize an error are determined and stored.
    Type: Grant
    Filed: September 23, 2021
    Date of Patent: February 28, 2023
    Assignee: Disney Enterprises, Inc.
    Inventors: Kenneth J. Mitchell, Charalampos Koniaris, Malgorzata E. Kosek, David A. Sinclair
  • Publication number: 20230048010
    Abstract: Provided herein are engineered nucleic acids (e.g., expression vectors, including viral vectors, such as lentiviral vectors, adenoviral vectors, AAV vectors, herpes viral vectors, and retroviral vectors) that encode OCT4; KLF4; SOX2; or any combination thereof that are useful, for example, in inducing cellular reprogramming, tissue repair, tissue regeneration, organ regeneration, reversing aging, or any combination thereof. Also provided herein are recombinant viruses (e.g., lentiviruses, alphaviruses, vaccinia viruses, adenoviruses, herpes viruses, retroviruses, or AAVs) comprising the engineered nucleic acids (e.g.
    Type: Application
    Filed: September 27, 2019
    Publication date: February 16, 2023
    Applicant: President and Fellows of Harvard College
    Inventors: David A. Sinclair, Yuancheng Lu
  • Patent number: 11500053
    Abstract: A radiofrequency (RF) localization system can include an RF sensing component, a signal-processing module and a visualization element. A plurality of antennas mounted on a belt, or on a helmet, or at least one extendable antenna attached within a backpack could be used for the RF sensing component. The signal-processing module can receive an RF Signal-of-Interest (SOI), and can further compute localization information for the RF SOI such as line of bearing, signal-to-noise ratio (SNR), and SSID information. The visualization element can be an augmented reality (AR) visor mounted on the helmet, or AR glasses. The signal-processing module can be mounted to the helmet, visor, or glasses, as applicable. The RF sensing component, signal module and said visualization element can be worn by the user, and can cooperate to provide hands free RF localization information in an AR format to an end user.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: November 15, 2022
    Assignee: United States of America as represented by the Secretary of the Navy
    Inventors: Jessica A. Sinclair, George Dewey Greenway, Shaun Christopher Easler
  • Patent number: 11464796
    Abstract: The invention relates to compositions of nicotinamide mononucleotide derivatives and their methods of use. The invention also relates to methods of preparing nicotinamide mononucleotide derivatives. The invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinamide mononucleotide derivative. The invention relates to methods of using nicotinamide mononucleotide derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for treating diseases and improving cell and tissue survival.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: October 11, 2022
    Assignee: Metro International Biotech, LLC
    Inventors: Karl D. Normington, David A. Sinclair, David J. Livingston, James M. McKearin, Bruce Szczepankiewicz, Jonathan N. Kremsky
  • Patent number: 11405371
    Abstract: A device for compressing subject data. the device comprises a communication link, the communication link capable of receiving a set of subject data; a compression module, the compression module configured to apply a compression algorithm to the set of subject data, the compression algorithm compressing the set of subject data using a reference string of subject data; and a transmission module, the transmission module configured to transmit the compressed subject data. The device further comprising an encryption module for encrypting the subject data.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: August 2, 2022
    Assignee: ARC BIO, LLC
    Inventors: Jason Michael Anderson, David A Sinclair, Alejandro Quiroz-Zarate, Roberto Olivares-Amaya, Ricardo Godinez-Moreno
  • Patent number: 11389469
    Abstract: Methods and compositions for preventing or treating peripheral neuropathy, cognitive deficits, inactivity, depression, chemotherapy and/or radiotherapy induced peripheral neuropathy and cognitive deficits, and improving cognitive performance, in a subject in need thereof are disclosed. The disclosed methods include the step of administering to the subject an effective amount of an agent that increases the level of NAD+ in the subject.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: July 19, 2022
    Assignee: NewSouth Innovations Pty Ltd
    Inventors: Lindsay Edward Wu, David A. Sinclair
  • Patent number: 11392805
    Abstract: A potentially small, gimballed, multi-sensor system employs a shared aperture for at least some of the image sensors. Applications include intelligence, surveillance, target acquisition and reconnaissance (ISTAR), and guiding autonomous vehicles. The system can actively blend images from multiple spectral bands for clarity and interpretability, provide remote identification of objects and material, provide anomaly detection, control lasers and opto-mechanics for image quality, and use shared aperture using folded optics.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: July 19, 2022
    Assignee: THE CHARLES STARK DRAPER LABORATORY, INC.
    Inventors: Matthew A. Sinclair, Adam Kelsey, Paul Aaron Bohn, Stephanie L. Golmon, Francis J. Rogomentich, Juha-Pekka Laine, Buddy A. Clemmer, David A. Landis
  • Patent number: 11287635
    Abstract: An optical system such as an imaging system, projecting system or combined imaging and projecting system, has complex dielectric coatings and/or reflecting polarizers to separate multiple spectral bands and/or polarizations on one or more of the system's curved mirrors.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: March 29, 2022
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Matthew A. Sinclair, Paul Aaron Bohn, Juha-Pekka Laine, Francis J. Rogomentich
  • Publication number: 20220074936
    Abstract: The disclosure provides methods, compositions, and kits for enhanced detection of microbes in samples and monitoring of antimicrobial activity in a subject.
    Type: Application
    Filed: November 17, 2021
    Publication date: March 10, 2022
    Applicant: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Mark J. CARTWRIGHT, Nazita GAMINI, Donald E. INGBER, Martin M. ROTTMAN, Michael SUPER, Julie A. TOMOLONIS, Karen A. SINCLAIR
  • Publication number: 20220042784
    Abstract: The present disclosure provides an OCT imaging system to reduce or eliminate frequency-domain aliasing artifacts. The frequency is shifted using a carrier frequency to define a sampling range substantially centered on the carrier frequency. An image of the sample is generated from a displayed imaging range that consists of a subset of the frequencies within the sampling range. Furthermore, the system may be configured to determine the carrier frequency such that a Nyquist frequency corresponding to the shifted frequency is extended beyond either an upper or a lower bound of an OCT quality envelope corresponding to the first portion of light. Additionally, the carrier frequency may be determined such that a lower bound of the OCT quality envelope is greater or less than a zero-frequency DC limit.
    Type: Application
    Filed: October 12, 2021
    Publication date: February 10, 2022
    Applicant: NINEPOINT MEDICAL, INC.
    Inventors: Eman Namati, Muhammad Al-Qaisi, Matthew A. Sinclair, Benedikt Graf, David Vader
  • Publication number: 20220014725
    Abstract: Techniques to facilitate compression of depth data and real-time reconstruction of high-quality light fields. A parameter space of values for a line, pairs of endpoints on different sides of the line, and a palette index for each pixel of a pixel tile of a depth image is sampled. Values for the line, the pairs of endpoints, and the palette index that minimize an error are determined and stored.
    Type: Application
    Filed: September 23, 2021
    Publication date: January 13, 2022
    Inventors: Kenneth J. MITCHELL, Charalampos KONIARIS, Malgorzata E. KOSEK, David A. SINCLAIR
  • Publication number: 20210403923
    Abstract: Provided herein are mutant reverse tetracycline transactivator (rtTA) proteins and engineered nucleic acids (e.g., viral vectors, including lentiviral vectors, adenoviral vectors, AAV vectors, herpes viral vectors, and retroviral vectors, and non-viral vectors, including RNA and plasmid DNA) that encode a mutant rtTA that are useful, for example, in regulating gene expression, inducing cellular reprogramming, tissue repair, tissue regeneration, organ regeneration, reversing aging, treating a disease (e.g., acute injuries, neurodegenerative disease, chronic diseases, proliferative diseases, cardiovascular diseases, genetic diseases, inflammatory diseases, autoimmune diseases, neurological diseases, hematological diseases, painful conditions, psychiatric disorders, metabolic disorders, cancers, aging, age-related diseases, and diseases affecting any tissue in a subject), or any combination thereof. Also provided herein are recombinant viruses (e.g.
    Type: Application
    Filed: September 27, 2019
    Publication date: December 30, 2021
    Applicant: President and Fellows of Harvard College
    Inventors: David A. Sinclair, Yuancheng LU, Noah Justin Davidsohn
  • Patent number: 11209432
    Abstract: The disclosure provides methods, compositions, and kits for enhanced detection of microbes in samples and monitoring of antimicrobial activity in a subject.
    Type: Grant
    Filed: June 11, 2020
    Date of Patent: December 28, 2021
    Assignee: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Mark J. Cartwright, Nazita Gamini, Donald E. Ingber, Martin Rottman, Michael Super, Julie A. Tomolonis, Karen A. Sinclair
  • Publication number: 20210371446
    Abstract: Provided herein are methods and compositions for preventing or treating aging, or an aging-related disorder, a disorder associated with inflammation, or for modulating an immune response in a subject in need thereof. In some embodiments, the methods comprise administering to the subject an effective amount of a compound of Formulas I-XIII.
    Type: Application
    Filed: October 16, 2019
    Publication date: December 2, 2021
    Inventors: David A. Sinclair, Conrad Rinaldi
  • Patent number: 11178844
    Abstract: The present invention comprises a rigid device capable of separating whey from yogurt when inserted into yogurt. The bottom of the device and a portion of the lower sides are walled to a height great enough to create a whey collecting reservoir. An accompanying ladle which fits within the device and is at a sufficient height to allow the collection of liquid into the ladle when inserted in the device may be included as part of a sales package.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: November 23, 2021
    Inventors: Sofia A. Sinclair, James D Sinclair
  • Patent number: 11175125
    Abstract: The present disclosure provides an OCT imaging system to reduce or eliminate frequency-domain aliasing artifacts. The frequency is shifted using a carrier frequency to define a sampling range substantially centered on the carrier frequency. An image of the sample is generated from a displayed imaging range that consists of a subset of the frequencies within the sampling range. Furthermore, the system may be configured to determine the carrier frequency such that a Nyquist frequency corresponding to the shifted frequency is extended beyond either an upper or a lower bound of an OCT quality envelope corresponding to the first portion of light. Additionally, the carrier frequency may be determined such that a lower bound of the OCT quality envelope is greater or less than a zero-frequency DC limit.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: November 16, 2021
    Assignee: NINEPOINT MEDICAL, INC.
    Inventors: Eman Namati, Muhammad Al-Qaisi, Matthew A. Sinclair, Benedikt Graf, David Vader